Literature DB >> 15361322

Fibromyalgia: present to future.

Robert Bennett1.   

Abstract

There has been a dramatic increase in our understanding of fibromyalgia throughout the past 14 years since the publication of the 1990 American College of Rheumatology classification criteria. Before 1990, and for most of the 20th century, fibromyalgia was considered to be predominantly a muscle disorder; now the critical abnormality is described as "central sensitization." However, central sensitization has to have an initial genesis and nociceptive stimuli from painful foci in muscle are increasingly recognized as being relevant to the development of fibromyalgia. Clinicians also recognize an association between the initiation of fibromyalgia and chronic psychologic stressors and inflammatory disorders. It has been more difficult to understand how two such apparently diverse events could affect central pain physiology. However, some clues are emerging from the role of diverse stimuli in activating glial cells and the role of disordered cytokine networks. Some predictions about future developments in fibromyalgia are ventured based on the current state of knowledge.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361322     DOI: 10.1007/s11916-996-0011-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  41 in total

1.  Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits.

Authors:  Hagit Cohen; Dan Buskila; Lily Neumann; Richard P Ebstein
Journal:  Arthritis Rheum       Date:  2002-03

2.  Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome.

Authors:  Roland Staud; Richard C Cannon; Andre P Mauderli; Michael E Robinson; Donald D Price; Charles J Vierck
Journal:  Pain       Date:  2003-03       Impact factor: 6.961

3.  Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome.

Authors:  S Gürsoy; E Erdal; H Herken; E Madenci; B Alaşehirli
Journal:  Rheumatol Int       Date:  2001-10       Impact factor: 2.631

Review 4.  Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.

Authors:  M J Owens; C B Nemeroff
Journal:  Clin Chem       Date:  1994-02       Impact factor: 8.327

Review 5.  Central sensitization in fibromyalgia and other musculoskeletal disorders.

Authors:  Lars Arendt-Nielsen; Thomas Graven-Nielsen
Journal:  Curr Pain Headache Rep       Date:  2003-10

6.  Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients.

Authors:  Savas Gursoy
Journal:  Clin Rheumatol       Date:  2002-06       Impact factor: 2.980

7.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.

Authors:  F Wolfe; H A Smythe; M B Yunus; R M Bennett; C Bombardier; D L Goldenberg; P Tugwell; S M Campbell; M Abeles; P Clark
Journal:  Arthritis Rheum       Date:  1990-02

8.  Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome?

Authors:  Hagit Cohen; Lily Neumann; Yehoshua Haiman; Michael A Matar; Joseph Press; Dan Buskila
Journal:  Semin Arthritis Rheum       Date:  2002-08       Impact factor: 5.532

Review 9.  Mitogen-activated protein kinases as potential targets for pain killers.

Authors:  Ru-Rong Ji
Journal:  Curr Opin Investig Drugs       Date:  2004-01
View more
  3 in total

Review 1.  The role of life stress in fibromyalgia.

Authors:  Boudewijn Van Houdenhove; Ulrich Egle; Patrick Luyten
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

Review 2.  Chronic widespread pain and fibromyalgia: two sides of the same coin?

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

Review 3.  The classification of fibromyalgia syndrome.

Authors:  W Müller; E M Schneider; T Stratz
Journal:  Rheumatol Int       Date:  2007-07-25       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.